请输入您的邮箱
发送邮件
当前位置:首页 > 产品中心
目录号 品名 CAS号 描述 详情
HD02964 Vincristine Sulfate 2068-78-2
HD02965 Vinblastine Sulfate 143-67-9
HD02966 Ixabepilone 219989-84-1
HD02963 Vinorelbine Tartrate 125317-39-7
HD00102 Actidione 66-81-9 Eukaryote protein synthesis inhibitor
HD00106 Siomycin 11017-43-9 Forkhead box M1 Inhibitor
HD00094 Bafilomycin 151499-39-7 V-ATPase inhibitor
HD02949 Ixazomib Citrate 1239908-20-3
HD01365 UCN-01 112953-11-4
HD01330 Cryptophycin 1 124689-65-2
HD01331 Telomestatin 265114-54-3
HD01062 Capecitabine 154361-50-9 Capecitabine is an oral prodrug that is converted to its active metabolite, 5-FU, by thymidine phosphorylase.
HD01060 Palbociclib 571190-30-2 Palbociclib, a cytotoxic drug for treating advanced breast cancer
HD01061 lenvatinib Mesylate 857890-39-2 E7080 is an orally active inhibitor of multiple receptor tyrosine kinases including VEGF, FGF and SCF receptors.
HD01058 Imatinib 152459-95-5 Imatinib is considered the standard first-line treatment in newly diagnosed patients with chronic-phase myeloid leukemia (CML).
HD01059 Regorafenib 755037-03-7 Regorafenib has been approved among the treatment options for patients with advanced stage colorectal cancer (CRC), hepatocellular carcinoma (HCC), and gastrointestinal stromal tumors (GIST)
HD01056 Erlotinib hydrochloride 183319-69-9 Erlotinib hydrochloride, a selective tyrosine kinase inhibitor approved for treatment of non-small cell lung cancer firstly.
HD01057 Ibrutinib 936563-96-1 Ibrutinib is a Bruton tyrosine kinase (BTK) inhibitor used in B-cell lymphoproliferative disorders.
HD01055 Sorafenib Tosylate 475207-59-1 Sorafenib tosylate (SORt) is an oral multikinase inhibitor used for treatment of advanced renal cell, liver, and thyroid cancers.
HD00490 14-O-Acetylindolactam V 91403-61-1 A PKC activator ,has antitumor activity

您是第 1094626 位访问者

电话:0086-571-89903882

邮箱:hdcsales@huidacollection.cn

Copyright © 2021 浙江珲达生物科技有限公司 浙ICP备20008217-2号 Designed by Wanhu 公安备案号 33010502006723

返回顶部
在线留言
提交